Wide Ranks

ALLK

Allakos Inc.

1.01

Top Statistics
Market Cap 90 M Forward PE -1.62 Revenue Growth 0.00 %
Current Ratio 6.08 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.2360 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 92 M Total Cash Per Share 1.04 Total Debt 39 M
Total Debt To Equity 53.62 Current Ratio 6.08 Book Value Per Share 0.8140
All Measures
Short Ratio 124.00 % Message Board Id finmb_225312313 Shares Short Prior Month 1 M
Return On Equity -1.22 City San Carlos Uuid 42c6c158-c38d-3e00-b41e-7332226eb737
Previous Close 0.8942 First Trade Date Epoch Utc 1 B Book Value 0.8140
Beta 1.02 Total Debt 39 M Volume 345941
Price To Book 1.24 Fifty Two Week Low 0.5400 Total Cash Per Share 1.04
Shares Short Previous Month Date 1 B Target Median Price 2.00 Audit Risk 6
Max Age 86400 Sand P52 Week Change 0.3133 Target Mean Price 2.88
Net Income To Common -178744992 Short Percent Of Float 0.0221 Implied Shares Outstanding 89 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 639930
Average Volume10days 639930 Total Cash 92 M Next Fiscal Year End 1 B
Held Percent Insiders 0.0232 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Share Holder Rights Risk 8 Regular Market Previous Close 0.8942
Target Low Price 1.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.9340
Open 0.8836 Free Cashflow -53340000 State CA
Dividend Yield 0.00 % Return On Assets -0.4875 Time Zone Short Name EST
Board Risk 10 Trailing Eps -2.03 Day Low 0.8836
Address1 825 Industrial Road Shares Outstanding 89 M Compensation Risk 10
Price Hint 4 Target High Price 7.00 Website https://www.allakos.com
52 Week Change -0.5450 Average Volume 667203 Forward Eps -0.6300
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 580.20 %
Is_sp_500 False Regular Market Day High 1.04 Profit Margins 0.00 %
Debt To Equity 53.62 Fifty Two Week High 3.41 Day High 1.04
Shares Short 1 M Regular Market Open 0.8836 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0156
Operating Cashflow -105398000 Currency USD Time Zone Full Name America/New_York
Market Cap 90 M Is_nasdaq_100 False Zip 94070
Quote Type EQUITY Industry Biotechnology Long Name Allakos Inc.
Overall Risk 10 Regular Market Day Low 0.8836 Held Percent Institutions 0.8163
Current Price 1.01 Address2 Suite 500 Enterprise To Ebitda -0.2360
Financial Currency USD Current Ratio 6.08 Industry Disp Biotechnology
Number Of Analyst Opinions 5 Country United States Float Shares 59 M
Two Hundred Day Average 1.03 Governance Epoch Date 1 B Enterprise Value 36 M
Forward PE -1.62 Regular Market Volume 345941 Ebitda -154723008
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States.

The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications.

The company was incorporated in 2012 and is headquartered in San Carlos, California.